| A multicenter phase II study of gemcitabine, capecitabine, and bevacizumab for locally advanced or metastatic biliary tract cancer RV Iyer, VK Pokuri, A Groman, WW Ma, U Malhotra, DM Iancu, C Grande, ... American Journal of Clinical Oncology 41 (7), 649-655, 2018 | 75 | 2018 |
| Predictors of complete pathologic response (pT0) to neoadjuvant chemotherapy in muscle-invasive bladder carcinoma VK Pokuri, JR Syed, Z Yang, EP Field, S Cyriac, R Pili, EG Levine, ... Clinical genitourinary cancer 14 (1), e59-e65, 2016 | 67 | 2016 |
| Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study S Samuel, S Mukherjee, N Ammannagari, VK Pokuri, B Kuvshinoff, ... PLoS One 13 (6), e0198809, 2018 | 62 | 2018 |
| Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors V Pokuri, MK Fong, R Iyer Current Oncology Reports, DOI 10.1007/s11912-015-0492-7, 2016 | 48 | 2016 |
| Interdigitating dendritic cell sarcoma VK Pokuri, M Merzianu, S Gandhi, J Baqai, TR Loree, S Bhat Journal of the National Comprehensive Cancer Network 13 (2), 128-132, 2015 | 41 | 2015 |
| Evaluation of the analgesic activity of standardized aqueous extract of Terminalia chebula in healthy human participants using hot air pain model CU Kumar, VK Pokuri, U Pingali Journal of Clinical and Diagnostic Research: JCDR 9 (5), FC01, 2015 | 32 | 2015 |
| Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience S Singla, CM LeVea, VK Pokuri, KM Attwood, MM Wach, ... Journal of Gastrointestinal Oncology 7 (3), 441, 2016 | 27 | 2016 |
| Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II Trial. IR Pokuri VK, Tomaszewski GM, Ait-Oudhia S, Groman A, Khushalani NI, Lugade ... Am J Clin Oncol., 2016 | 27* | 2016 |
| A randomized, double-blind, placebo-controlled, cross-over study to evaluate analgesic activity of Terminalia chebula in healthy human volunteers using a mechanical pain model VK Pokuri, CU Kumar, U Pingali Journal of Anaesthesiology Clinical Pharmacology 32 (3), 329-332, 2016 | 24 | 2016 |
| A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia … P Usharani, C Nutalapati, VK Pokuri, CU Kumar, G Taduri Clinical pharmacology: advances and applications, 51-59, 2016 | 24 | 2016 |
| Levamisole—adulterated in cocaine causing agranulocytosis, vasculopathy, and acquired protein S deficiency I Dy, V Pokuri, J Olichney, P Wiernik Annals of hematology 91, 477-478, 2012 | 15 | 2012 |
| Bridging sunitinib exposure to time‐to‐tumor progression in hepatocellular carcinoma patients with mathematical modeling of an angiogenic biomarker S Ait‐Oudhia, DE Mager, V Pokuri, G Tomaszewski, A Groman, P Zagst, ... CPT: pharmacometrics & systems pharmacology 5 (6), 297-304, 2016 | 13 | 2016 |
| Bing–Neel syndrome in a patient with Waldenstrom's macroglobulinemia: a challenging diagnosis in the face of normal brain imaging N Gupta, S Gupta, O Al Ustwani, V Pokuri, H Hatoum, S Bhat CNS Neuroscience & Therapeutics 20 (10), 945, 2014 | 9 | 2014 |
| Strategies to circumvent testosterone surge and disease flare in advanced prostate cancer: emerging treatment paradigms VK Pokuri, H Nourkeyhani, B Betsy, L Herbst, M Sikorski, E Spangenthal, ... Journal of the National Comprehensive Cancer Network 13 (7), e49-e55, 2015 | 8 | 2015 |
| Adequacy of malignant pleural effusion for epidermal growth factor receptor mutation analysis using the pyrosequencing method H Hatoum, Y Lourdes, SS Dhillon, GK Dy, K Attwood, V Pokuri, K Harris Pleura 2, 2373997515616584, 2015 | 3 | 2015 |
| Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapy VK Pokuri, B Xu, V Neppalli, J Czyzyk, F Berenji, SA Holstein, ... Annals of hematology 94, 1067-1068, 2015 | 2 | 2015 |
| A case of unusual mast cell response with interstitial cystitis-like symptoms to neoadjuvant chemotherapy for muscle-invasive transitional cell carcinoma of the bladder V Pokuri, N Sule, Y Soofi, B Xu, K Guru, S George Journal of the National Comprehensive Cancer Network 11 (12), 1459-1463, 2013 | 2 | 2013 |
| A novel treatment approach prolonging survival in an uncommon metastatic primary bladder adenocarcinoma VK Pokuri, N Sule, C Perfetto, M Duff, C Kopp, K Guru, D Shah, S George J Community Support Oncol 14 (2), 72-5, 2016 | 1 | 2016 |
| Safety and tolerability of sequencing somatostatin analogs (octreotide to lanreotide depot) in the treatment of neuroendocrine tumors: an institutional case series MK Fong, VK Pokuri, A Causebrook, R Iyer Int J Clin Exp Med 9 (10), 19771-19777, 2016 | 1 | 2016 |
| Aurora Kinase A and Gastrointestinal Malignancies VK Pokuri, M Opyrchal, PM Boland Int J Cancer Res Mol Mech 1 (3), 2015 | 1 | 2015 |
